menu
    • menu

    Company profile for Forbion

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Forbion is a leading European venture capital firm that helps companies bridge research and development through the team’s expertise in drug development and company building. Forbion is signatory to the United Nations Principles for Responsible Investment further demonstrating our philosophy that investments in companies should positively impact the health and well-being of patients.Forbion contributes to the health and well...
    Forbion is a leading European venture capital firm that helps companies bridge research and development through the team’s expertise in drug development and company building. Forbion is signatory to the United Nations Principles for Responsible Investment further demonstrating our philosophy that investments in companies should positively impact the health and well-being of patients.Forbion contributes to the health and well-being of patients worldwide. Our companies have positively affected almost half a million patients in the areas.Forbion impacts the health and well-being of patients

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ForbionNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Gooimeer 2-35 1411 DC Naarden
    Telephone
    Telephone
    +31 35 699 30 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://forbion.com/en/portfolio/covicept_therapeutics
    Linkedin
    Linkedin
    https://www.linkedin.com/company/forbion-capital-partners/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ForbionLifeSci

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novartis-Backed Protego Secures $130M for Pivotal Amyloidosis
    Novartis-Backed Protego Secures $130M for Pivotal Amyloidosis

    01 Dec 2025

    // BIOSPACE

    https://www.biospace.com/business/novartis-backed-protego-eyes-pivotal-amyloidosis-study-with-130m-series-b

    BIOSPACE
    01 Dec 2025
    Share Share
    Elevara Secures $70M Series A For Rheumatoid Arthritis Trial
    Elevara Secures $70M Series A For Rheumatoid Arthritis Trial

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3170818/0/en/Elevara-Medicines-Raises-70-Million-Series-A-to-Advance-Phase-2-Rheumatoid-Arthritis-Trial-and-Expand-Pipeline.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    Sparrow Pharma Secures $95m Series B For Type 2 Diabetes Therapy
    Sparrow Pharma Secures $95m Series B For Type 2 Diabetes Therapy

    24 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/24/3155451/0/en/Sparrow-Pharmaceuticals-Announces-95-Million-Series-B-Financing-to-Advance-Targeted-Therapy-for-Type-2-Diabetes.html

    GLOBENEWSWIRE
    24 Sep 2025
    Share Share
    Forbion raises €1.3B over 2 funds in largest haul yet
    Forbion raises €1.3B over 2 funds in largest haul yet

    19 Apr 2023

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/what-vc-slowdown-forbion-raises-eu13b-over-two-funds-largest-haul-yet

    FIERCE BIOTECH
    19 Apr 2023
    Share Share
    Sofinnova, Forbion back $70M push across finish line for rare antifungal drug
    Sofinnova, Forbion back $70M push across finish line for rare antifungal drug

    04 Aug 2022

    // Amber Tong ENDPTS

    https://endpts.com/sofinnova-forbion-back-70m-push-across-finish-line-for-rare-antifungal-treatment/

    Amber Tong ENDPTS
    04 Aug 2022
    Share Share
    Forbion Co-leads $70M Financing of F2G to Advance Antifungal Agent Olorofim
    Forbion Co-leads $70M Financing of F2G to Advance Antifungal Agent Olorofim

    04 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/04/2491978/0/en/Forbion-Co-leads-70-Million-Financing-of-F2G-to-Advance-Development-and-Commercialization-of-New-Antifungal-Agent-Olorofim.html

    GLOBENEWSWIRE
    04 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search